Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study history shows the recruitment status changing to not recruiting participants, clarifying that enrollment is closed; the record also notes a new version (Revision: v3.6.0) while the previous version (Revision: v3.5.5) was removed.SummaryDifference0.5%

- Check18 days agoChange DetectedA new revision (v3.5.5) has been added to the record history, indicating the study record has been updated. The previous revision (v3.5.4) was removed from the list.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision label v3.5.4 is added to the study record history, indicating an update to the page's version history. The previous revision v3.5.3 is removed from the visible history.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History, and the previous revision entry v3.5.2 was removed, reflecting an update to the page's version history.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision v3.5.2 was added to the record history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded revision v3.5.0 and deleted revision v3.4.3 from the history.SummaryDifference0.1%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.